Trial Profile
A Proof of Concept Clinical Trial of the Combination Cediranib-Olaparib at the Time of Disease Progression on Olaparib in Ovarian Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Cediranib (Primary) ; Olaparib (Primary)
- Indications Ovarian cancer
- Focus Proof of concept; Therapeutic Use
- 11 Jun 2018 Status changed from active, no longer recruiting to completed.
- 30 Oct 2017 Planned End Date changed from 1 Dec 2017 to 1 Jun 2019.
- 30 Oct 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.